Welcome to our dedicated page for General Motors Co SEC filings (Ticker: GM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on General Motors Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into General Motors Co's regulatory disclosures and financial reporting.
General Motors (GM): Form 144 insider sale notice. A company insider filed to sell 260,600 shares of GM common stock, with an aggregate market value $17,315,943.87. The filing lists an approximate sale date of 10/22/2025 on the NYSE.
The shares to be sold were acquired as 33,030 performance shares on 02/08/2025 and via a 227,570 stock option exercise on 10/22/2025 paid in cash. GM reported 932,861,303 shares outstanding, presented here as a baseline reference.
Recent insider sales disclosed in the notice include Mark Reuss selling 136,161 shares on 09/25/2025 for $8,185,175.76 and 26,869 shares on 09/24/2025 for $1,612,871.65. This Form 144 indicates an intent to sell and outlines the acquisition sources and recent activity.
General Motors (GM) reported Q3 2025 results showing steady revenue but a sharp earnings decline. Total net sales and revenue were $48.6 billion, nearly flat year over year, while net income attributable to stockholders fell to $1.33 billion from $3.06 billion. Diluted EPS was $1.35, compared with $2.68 a year ago.
Operating income decreased to $1.08 billion from $3.65 billion as automotive cost of sales rose. GM Financial continued to contribute, with revenue of $4.34 billion versus $4.02 billion. For the first nine months, revenue was $139.7 billion and diluted EPS was $6.64. Cash from operating activities reached $20.1 billion year to date, supporting $3.51 billion of share repurchases and $519 million of dividends. Cash and cash equivalents were $22.9 billion, and total equity was $68.4 billion at September 30, 2025. Shares outstanding were 932,861,303 as of October 10, 2025.
GM noted EV-related inventory allowances of $1.8 billion and recorded $260 million of charges tied to strategic realignment of EV capacity. The company issued $2.0 billion of senior notes in May and redeemed $1.25 billion maturing in October 2025.
General Motors Company filed an 8-K announcing it furnished its 2025 third quarter consolidated earnings materials. The company issued a news release and supplemental materials, provided as Exhibit 99.1.
GM also made charts presented to securities analysts available on its investor website at www.gm.com/investors/earnings-releases.html. The information under Item 2.02 and Exhibit 99.1 is furnished, not filed, and is not incorporated by reference except as specifically stated.
General Motors reported material impairments tied to a strategic realignment of its electric-vehicle capacity. The Audit Committee approved charges of $1.6 billion in GM North America for the three months ended September 30, 2025. This includes $1.2 billion of non-cash impairment and $0.4 billion of charges primarily for contract cancellation fees and commercial settlements that will have a cash impact.
GM cited recent U.S. policy changes—ending certain EV purchase tax incentives and easing emissions rules—which it expects will slow EV adoption, prompting a reassessment of EV capacity and its manufacturing footprint. The company noted the reassessment, including battery component investments, is ongoing and it is reasonably possible additional future material cash and non-cash charges could be recognized. GM said these amounts, and other insignificant charges this quarter, will be reflected as adjustments in its non-GAAP measures. The realignment does not impact the current retail portfolio of Chevrolet, GMC and Cadillac EVs in production, which remain available.
Harvey Rory, Executive Vice President of General Motors Co (GM), reported changes in his beneficial ownership on transactions dated 09/26/2025. The filing shows an acquisition of 6,600 shares of GM common stock at $52.16 per share and a contemporaneous sale of 6,600 shares at $61.95. After these transactions Mr. Rory beneficially owned 15,113 shares (following the acquisition) and 8,513 shares (following the sale) as reported in Table I. Table II notes employee stock option activity tied to a $52.16 exercise price for 6,600 options; the filing states these options were granted on February 18, 2021 and are fully vested. The form is signed by an attorney-in-fact on behalf of Mr. Rory on 09/30/2025.
Christopher Hatto, Vice President & CAO of General Motors Co (GM), reported multiple transactions on 09/26/2025. The Form 4 shows non-derivative purchases and sales and related option activity. The reporting person acquired and disposed of common stock in matched pairs: purchases of 9,584 and 13,816 shares (reported at $41.40) and sales of 9,584 and 13,816 shares at weighted average prices in the range $61.00–$61.10. After the reported transactions the filing shows 12,007 shares beneficially owned. The filing also reports employee stock options: 9,584 options granted 02/13/2018 (fully vested) and 13,816 options granted 02/07/2023 (two‑thirds vested, remainder vests 02/07/2026). The report is signed by an attorney‑in‑fact on 09/30/2025.
Mark L. Reuss, President of General Motors Co. (GM), reported option exercises and open-market sales on September 24-25, 2025. He exercised a total of 80,000 employee stock options with a $39 exercise price (13,715 on 09/24 and 66,285 on 09/25). Concurrently, he sold a total of 163,030 shares in multiple transactions at weighted average prices of approximately $60.03 to $60.12 per share. After these transactions, he beneficially owned 131,036 shares and held 80,000 outstanding options exercisable through 02/13/2029. The filing discloses that the sales occurred in multiple tranches and provides weighted average prices and ranges for the transactions.
Form 144 filed for General Motors Co (GM) reports a proposed sale of 6,600 common shares valued at $399,894.00 to be sold on 09/26/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The shares were acquired on 09/26/2025 via exercise of stock options and paid for in cash the same day. The filing also discloses two Rule 10b5-1 sales by the same person within the past three months: 23,977 shares on 08/05/2025 for $1,271,058.45 and 4,459 shares on 09/12/2025 for $267,317.05. The filer certifies no undisclosed material adverse information and references a potential 10b5-1 trading plan.
Form 144 filed for General Motors Co (GM) reports a proposed sale of 23,400 shares of common stock through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $1,417,806. The filing states the shares were acquired and will be sold on 09/26/2025 by exercise of stock options with cash payment. The issuer has 952,077,801 shares outstanding per the filing. The notice also discloses two prior 10b5-1 sales by the same person during the past three months: 14,667 shares on 08/27/2025 for $865,353 and 36,804 shares on 08/13/2025 for $2,027,969.84.
Form 144 filed for General Motors Co (GM) reporting proposed sale of 136,161 common shares with an aggregate market value of $8,185,175.76, to be sold through Morgan Stanley Smith Barney LLC on the NYSE approximately on 09/25/2025. The filing lists acquisition details: 50,000 performance shares acquired 02/12/2023, 66,285 shares from a stock option exercise on 09/25/2025 (paid in cash), and 19,876 performance shares acquired 02/08/2025. The notice also discloses a prior sale by Mark Reuss of 26,869 shares on 09/24/2025 for $1,612,871.65. The filer attests no undisclosed material adverse information.